Press release
Animal Nutrition
March 4, 2019

Evonik invites VIV Asia 2019 visitors to join its digital journey

  • Precision Livestock Farming approach to help manage flocks
  • Holistic method for better understanding, optimized status and appropriate action
  • New digital approach being demonstrated at VIV Asia 2019

Evonik is promoting its holistic approach to livestock management at this year’s VIV Asia in Bangkok, Thailand, from 13 to 15 March.

Johann Fickler, Animal Nutrition’s Vice President Know-how, Services & Digitalization, explains: “Managing livestock is getting more complex and traditional approaches are no longer sufficient. Technological developments now allow producers to use sensors and software to help them better understand the condition of their flocks, helping increase the performance or improve uniformity.

“Precision Livestock Farming is about going beyond just gathering data. It combines science-based know-how with proven amino services, and innovative nutritional and health concepts, all embedded into specific digital solutions. This holistic approach means growers can better understand and optimize the status of their animals and take appropriate action, including early preventative measures.

“The result is improved livestock production performance, increased uniformity, higher efficiency, and ultimately better margins for the grower. The even better news is that the approach is easily scalable and so it suits processes within the entire livestock production. This truly is a digital journey worth taking.”

Delegates at VIV Asia are invited to attend a technical session on ‘Introduction to Evonik Precision Livestock Farming’ to discover the latest information about this topic on Wednesday 13 March at 14:30 in Room 212. To guarantee a place, delegates should register online at:

Attendees at VIV Asia can also meet the Evonik Animal Nutrition team at booth H102-2350 where they can learn about how the feed additive specialist company is ‘Sciencing the global food challenge’ through the development of a range of products and services.

This includes PROXYMet – a MetAMINO® based product which achieves the same bioefficacy as MHA-FA – and which has had many successful trials in India and Asia South. There are also services such as AMINONIR® – which assists with specific calibrations for the prediction of crude protein, dry matter, essential and non-essential amino acids for all major feed ingredients – and AMINOSys® – which comprises consulting, hardware and software solutions for micro-ingredient handling and dosing in feed mills.

Delegates can learn more about the forthcoming opening of the new Evonik MetAMINO® plant in Singapore as well.

Evonik is also a sponsor of the 6th Global Feed and Food Congress (GFFC) which brings together leaders from the global feed and food chain in Bangkok from 11 to 13 March.

About Evonik
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2017, the enterprise generated sales of €14.4 billion and an operating profit (adjusted EBITDA) of €2.36 billion.

About Nutrition & Care
The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 8,250 employees, and generated sales of around €4.5 billion in 2017.

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.